Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment of cutaneous T-cell lymphoma in Oncology and Therapy, highlighting favorable efficacy and safety outcomes. After 12 weeks, 60% of HyBryte-treated patients achieved treatment success compared to 20% for Valchlor, with greater average improvement and no treatment-related adverse events reported for HyBryte, while Valchlor patients experienced multiple adverse…
Massimo Group (NASDAQ: MAMO) reported financial results for the fiscal year ended Dec. 31, 2025, highlighting a significant expansion in gross margin to approximately 37.5% from 29.7% in 2024, driven by product mix optimization and cost efficiencies. While revenue declined to $71.8 million as the company rebalanced dealer inventory and prioritized pricing discipline, Massimo maintained profitability with $1.5 million in net income…
ParaZero Technologies (NASDAQ: PRZO) announced it has signed a framework agreement with a Tier-1 international company specializing in autonomous drone interception, including integration of its DefendAir Net Pod into the client’s new drone platform. The agreement includes a minimum purchase of 2,000 customized units and is expected to expand global deployment of ParaZero’s Counter-UAS solutions while enhancing drone interception capabilities. To view the…
Rail Vision (NASDAQ: RVSN) reported financial results for the second half and full year ended Dec. 31, 2025, citing revenue growth and continued operational progress as it expands its global footprint. The company advanced deployments with Israel Railways, secured follow-on orders in Latin America, expanded into Central America and launched a proof of concept in India, underscoring increasing adoption of…
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended Dec. 31, 2025, outlining a year marked by leadership changes, clinical progress and strategic expansion. The company advanced development of its lead compound LB-100, expanded clinical trials with additional sites and increased enrollment, completed the acquisition of Liora Technologies Europe Ltd. to enhance…
Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently finished its first full reporting period as the world’s largest Solana treasury. A recent article shares details from an announcement of the company’s fiscal first quarter 2026 operating and financial results, updates, milestones and future plans. “As of Dec. 31, 2025, Forward Industries has SOL holdings…
U.S. Energy (NASDAQ: USEG) announced the pricing of an underwritten public offering of 8.8 million shares at $1.00 per share for gross proceeds of approximately $8.8 million, with closing expected March 10, 2026, subject to customary conditions. The company said it intends to use net proceeds to fund growth capital for its industrial gas development project,…
Beeline Holdings (NASDAQ: BLNE) reported fourth-quarter 2025 net revenue of $2.5 million, up 127% year over year, on origination volume of $84.7 million, a 44% increase, as the company continued improving loan economics with a 31% rise in average revenue per loan and an 18% reduction in cost per loan. The company also launched its BeelineEquity platform, closing…
SEGG Media (NASDAQ: SEGG, LTRYW) announced the appointments of Daniel Bailey as chief commercial officer and Jack Clarke as chief strategy officer following its Veloce acquisition, as the company advances a 90-day plan focused on integration, execution, and monetization. The new executives bring experience scaling Veloce Media Group and driving global partnerships and revenue growth, with…
Perpetuals.com (NASDAQ: PDC) announced that its CySEC-regulated multilateral trading facility has received approval to expand its MiFID II license to include reception, transmission and execution of client orders, enabling direct client access without intermediaries. The company said the approval makes it the first European crypto derivatives venue to combine a fully regulated MTF with execution and…
Soligenix (NASDAQ: SNGX) announced the European Commission has granted orphan drug designation to dusquetide (SGX945) for the treatment of Behçet Disease, following a positive recommendation from the European Medicines Agency and supportive Phase 2a data demonstrating biological efficacy and safety. The designation provides up to 10 years of market exclusivity in the European Union and adds to existing FDA orphan and…
Alliance Creative Group (OTC: ACGX) reported 2025 results including gross income of $364,082, net income of $81,269 and total assets of approximately $1.07 million, reflecting a lean operating model and improved financial position. The company highlighted strategic progress in building AI-powered media and marketing platforms, expanding digital assets and maintaining key investments, including its stake in PeopleVine, as it positions…
Safe Pro Group (NASDAQ: SPAI), according to reporting by Military AI, demonstrated its AI-powered drone decision-support system during a U.S. Army Transforming in Contact 2.0 exercise at Fort Hood, where soldiers used the technology to convert drone imagery into real-time battlefield intelligence. The system identified threats such as landmines and unexploded ordnance, generated 2D and 3D terrain maps for mission…
Datavault AI (NASDAQ: DVLT) announced a partnership with undefeated British heavyweight boxer Moses Itauma as part of its strategy to expand its athlete-focused name, image and likeness digital asset platform, currently in development with Sports Illustrated. The collaboration, centered around Itauma’s March 28, 2026 fight in Manchester, is expected to showcase the company’s technology while exploring future NIL monetization opportunities, including digital content and fan engagement initiatives,…
Linkers Industries Limited (NASDAQ: LNKS) announced it has entered into a non-binding memorandum of understanding to acquire additional equity interests in LPW Electronics Co. Ltd. in Thailand, which could raise its ownership from 20% to up to 49% if completed. The proposed transaction is intended to expand Linkers’ manufacturing capabilities and scale through LPW’s 6,500-square-meter facility serving multinational automotive and industrial customers. The deal remains subject to…
ParaZero Technologies (NASDAQ: PRZO) announced the closing of its previously announced registered direct offering with a single institutional investor, generating approximately $4 million in gross proceeds through the sale of 5,333,333 ordinary shares and pre-funded warrants at $0.75 per share. The transaction, which closed March 24, 2026, will support general corporate purposes and working capital, with Aegis Capital Corp.…
Rail Vision (NASDAQ: RVSN) announced that its ordinary shares have begun trading on the Frankfurt Stock Exchange under the symbol C80, while continuing to trade on the Nasdaq Capital Market under RVSN. The company said the dual listing is expected to enhance visibility and trading liquidity in Europe, broaden its investor base and provide expanded access…
NRx Pharmaceuticals (NASDAQ: NRXP) announced the filing of its Form 10-K for the year ended Dec. 31, 2025, highlighting progress across its clinical-stage pipeline and HOPE Therapeutics operations, including advancing two drug candidates toward FDA approval and opening its first HOPE Therapeutics clinics focused on neuroplastic care. The company reported a reduced operating loss of $16.2…
ParaZero Technologies (NASDAQ: PRZO) announced it has entered into a definitive agreement for a registered direct offering with a single institutional investor expected to generate approximately $4 million in gross proceeds through the sale of 5,333,333 ordinary shares (or pre-funded warrants) at $0.75 per share. The company said proceeds will be used for general corporate purposes and…
Soligenix (NASDAQ: SNGX) announced that new supportive trial data for HyBryte(TM) in the treatment of cutaneous T-cell lymphoma will be presented at the United States Cutaneous Lymphoma Consortium Workshop on March 26, 2026, ahead of the American Academy of Dermatology Annual Meeting. The presentations will highlight positive results from a long-term treatment study and a comparative analysis versus Valchlor(R),…